CIBC Private Wealth Group
HQL

CIBC Private Wealth Group’s abrdn Life Sciences Investors HQL Stock Holding History

CIBC Private Wealth Group’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29
Closed -$416 – 3192
2024
Q2 		$416 Sell
29
-2,440
-99% -$33K ﹤0.01% 2997
2024
Q1 		$33.3K Buy
+2,469
New +$34.2K ﹤0.01% 1837

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

CIBC Private Wealth Group's HQL Position: Q3 2024 in Review

CIBC Private Wealth Group sold out of abrdn Life Sciences Investors (HQL) in Q3 2024, closing a stake of 29 shares — an estimated $416 sold.

CIBC Private Wealth Group first reported a position in HQL in Q1 2024 and held it in 2 quarters. The position peaked at $33.3K in Q1 2024. 74 funds tracked by Wall St. Rank hold HQL as of Q3 2024.

  • CIBC Private Wealth Group reported no remaining abrdn Life Sciences Investors position as of Q3 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 29 abrdn Life Sciences Investors shares in Q3 2024, an estimated $416.
  • CIBC Private Wealth Group first reported a position in abrdn Life Sciences Investors in Q1 2024 and held it in 2 quarters.
  • CIBC Private Wealth Group's abrdn Life Sciences Investors position peaked at $33.3K in Q1 2024.
  • 74 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2024.

Based on CIBC Private Wealth Group's 13F filing for Q3 2024, filed 13 Nov 2024.